Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus
The Lancet Primary Care · 2026-09 · 2 (9) · 100205
DOI: 10.1016/j.lanprc.2026.100205 ↗Kurz gefasst
Delphi-Studie in der Zeitschrift The Lancet Primary Care, 2026-09. Verfasst von Gong Feng und 39 weiteren Autor:innen. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Santé, National Natural Science Foundation of China, National Institute for Health and Care Research.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease worldwide, with general practitioners and family doctors (collectively referred to as GPs) playing a key role in its management. However, numerous challenges persist in primary care settings. We aimed to develop consensus statements and recommendations to support MASLD management in primary care through an international collaboration of multidisciplinary experts. Experts were selected on the basis of clinical and academic expertise, publication record, involvement in guideline or consensus work, and geographical representation. 51 experts from 30 countries across six continents participated in round 1, and 49 experts from 29 countries participated in round 2. The expert panel included hepatologists or gastroenterologists, GPs, endocrinologists, cardiologists, and experts from other relevant disciplines. Agreement rose from 1271 (73·3%) of 1734 in round 1 to 1119 (87·8%) of 1274 in round 2, yielding 26 consensus statements across six domains: use of screening and non-invasive diagnostic tools; referral pathways for individuals at risk of advanced fibrosis; treatment goals emphasising weight reduction, dietary modifications, physical activity, and metabolic risk control; structured follow-up based on dynamic changes in clinical and fibrosis indicators, with assessment of extrahepatic complications; the role of GPs in patient education, lifestyle interventions, and coordination of multidisciplinary care; and training frameworks and system-level support to enhance primary care capacity. This expert consensus provides a systematic guide for managing MASLD in primary care, emphasising the key role of GPs in early screening, patient education, and behavioural interventions. It also offers a practical management framework for primary care worldwide and provides essential guidance for future research and policy development.
Förderung
- Santé
- National Natural Science Foundation of China
- National Institute for Health and Care Research
- National Science and Technology Major Project
- National Health and Medical Research Council
- Xi'an Medical University
- Natural Science Basic Research Program of Shaanxi Province
- Medical Research Future Fund
Zitieren
APA
Feng, G., Gong, S., Tacke, F., Valenti, L., Muthiah, M., Kato, K., Yu, Z., Targher, G., Byrne, C. D., Allam, M. F., Chan, W. K., Yilmaz, Y., Ren, J., Arab, J. P., Sebastiani, G., George, J., Kim, S. U., Zhao, Y., Bwa, A. H., …, & Ahmed, M. (2026). Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus. The Lancet Primary Care, 2(9), 100205. https://doi.org/10.1016/j.lanprc.2026.100205
Vancouver
Feng G, Gong S, Tacke F, Valenti L, Muthiah M, Kato K, et al. Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus. The Lancet Primary Care. 2026;2(9):100205. doi:10.1016/j.lanprc.2026.100205
BibTeX
@article{Feng2026,
author = {Feng, Gong and Gong, Shouping and Tacke, Frank and Valenti, Luca and Muthiah, Mark and Kato, Koki and Yu, Zhaoxiang and Targher, Giovanni and Byrne, Christopher D and Allam, Mohamed Farouk and Chan, Wah Kheong and Yilmaz, Yusuf and Ren, Jingjing and Arab, Juan Pablo and Sebastiani, Giada and George, Jacob and Kim, Seung Up and Zhao, Yang and Bwa, Aung Hlaing and Alswat, Khalid A and Zhang, Weiru and Parretti, Helen M and Moreno, Laura Elizabeth and Treeprasertsuk, Sombat and Duseja, Ajay and Jensen, Martin Bach and Feng, Mei and Spearman, Catherine Wendy and Meza-Torres, Bernardo and Mustika, Syifa and Méndez-Sánchez, Nahum and Chew, Boon How and Fernández, Marlen Ivón Castellanos and Mi, Man and Muendo, Nicholas Kyalo and Lam, Thomas Yuen Tung and Dong, Aimei and Shubrook, Jay H and Gao, Xiaotong and Ahmed, Marium},
title = {Metabolic dysfunction-associated steatotic liver disease in primary care: an international Delphi consensus},
journal = {The Lancet Primary Care},
year = {2026},
volume = {2},
number = {9},
pages = {100205},
doi = {10.1016/j.lanprc.2026.100205}
}
EUVIMED